dermatologic pharmacology - ju medicine · dermatologic pharmacology variables affecting...

68
Dermatologic Pharmacology Dr. Alia Shatanawi

Upload: others

Post on 28-Mar-2020

11 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Dermatologic Pharmacology

Dr. Alia Shatanawi

Page 2: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Dermatologic Pharmacology

Variables affecting Pharmacologic Response:

• Regional variation in drug penetration

• Concentration gradient:

Increasing the concentration gradient increases the mass of drug transferred per unit time

• Dosing schedule

• Vehicles and occlusion

Page 3: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Percutaneous Absorption.

Page 4: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Dermatologic Formulations

• Tinctures • Wet dressings • Lotions • Gels • Powders • Pastes • Creams • Ointments

Page 5: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Adverse Effects of Dermatologic Preparations

• Burning or stinging sensation

• Drying and irritation

• Pruritus

• Erythema

• Sensitization

• Staining

• Superficial erosion

Page 6: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Topical Antibacterial Agents

• Bacitracin.

• Gramicidin.

– Gram-positive bacteria. • Polymyxin B:

• Neomycin.

• Gentamicin.

– Gram-negative bacteria.

Page 7: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

• Frequently used in combination with other agents (polymyxin B and neomycin)

• Form: creams, ointments, and aerosol preparations

• Usually Antiinflammatory agents added – (Hydrocortisone)

– MOA??

Bacitracin

Page 8: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

8

MUPIROCINMupirocin (pseudomonic acid A) is structurally unrelated to other currently available topical antibacterial agents. Most gram-positive aerobic bacteria, including methicillin-resistant S aureus (MRSA), are sensitive to mupirocin .

It is effective in the treatment of impetigo caused by S aureus and group A β-hemolytic streptococci.Intranasal mupirocin ointment for eliminating nasal carriage of S aureus may be associated with irritation of mucous membranes caused by the polyethylene glycol vehicle. Mupirocin is not appreciably absorbed systemically after topical application to intact skin.

Page 9: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

9

RETAPAMULINRetapamulin is a semisynthetic pleromutilin derivative effective in the treatment of uncomplicated superficial skin infection caused by group A β-hemolytic streptococci and S aureus , excluding MRSA.

Topical retapamulin 1% ointment is indicated for use in adult and pediatric patients, 9 months or older, for the treatmentof impetigo.

Recommended treatment regimen is twice-daily application for 5 days. Retapamulin is well tolerated with only occasional local irritation of the treatment site..

Page 10: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

10

POLYMYXIN B SULFATEPolymyxin B is a peptide antibiotic effective against gram-negativeorganisms, including Pseudomonas aeruginosa, Escherichia coli ,enterobacter, and klebsiella. Most strains of proteus and serratiaare resistant, as are all gram-positive organisms.

NEOMYCIN & GENTAMICINNeomycin and gentamicin are aminoglycoside antibiotics active against gram-negative organisms, including E coli , proteus, klebsiella,and enterobacter. Gentamicin generally shows greater activity against P aeruginosa than neomycin. Gentamicin is also more active against staphylococci and group A β-hemolytic streptococci.Widespread topical use of gentamicin, especially in a hospital environment, should be avoided to slow the appearance of gentamicin-resistant organisms.

Page 11: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

• Clindamycin

• Erythromycin

• Metronidazole

• Sodium sulfacetamide

Topical Antibacterials in Acne

Page 12: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:
Page 13: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Clindamycin• 10% absorbed, so, possibility of Pseudomembranous

colitis • The hydroalcoholic vehicle and foam formulation

(Evoclin) …………may cause drying and irritation of the skin, with complaints of burning and stinging.

• The water-based gel and lotion formulations….. well tolerated and less likely to cause irritation. Allergic contact dermatitis is uncommon.

• Clindamycin is also available in fixed-combination topical gels with benzoyl peroxide (Acanya, BenzaClin, Duac), and with tretinoin (Ziana).

Page 14: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Metronidazole

• Effective in the treatment of rosacea. • The mechanism of action is unknown, but it may

relate to the inhibitory effects of metronidazole on Demodex brevis; This drug may act as an anti-inflammatory agent by direct effect on neutrophil cellular function

• Adverse local effects include dryness, burning, and stinging.

• Less drying formulations may be better tolerated (MetroCream, MetroLotion, and Noritate cream).

• Caution should be exercised when applying metronidazole near the eyes to avoid excessive tearing.

Page 15: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Metronidazole

• Metronidazole nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa

• is selectively toxic for amebae and for anaerobic organisms (including bacteria).

• Mechanism of action Some anaerobic protozoan parasites (including amebae)

possess ferrodoxin-like electron transport proteins that participate in metabolic electron removal reactions.

The nitro group of metronidazole is able to serve as an electron acceptor, forming reduced cytotoxic compounds that bind to proteins and DNA to result in cell death.

Page 16: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Erythromycin• In topical preparations, erythromycin base rather

than a salt is used to facilitate penetration

• One of the possible complications of topical therapy is the development of antibiotic-resistant strains of organisms, including staphylococci

• Adverse local reactions to erythromycin solution may include a burning sensation at the time of application and drying and irritation of the skin

• Erythromycin is also available in a fixed combination

preparation with benzoyl peroxide (Benzamycin) for topical treatment of acne vulgaris.

Page 17: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Antifungal Chemotherapy

• Fungal infections are termed mycoses and can be divided into:

(1) Superficial infections: affecting skin, nails, scalp

or mucous membranes (2) Systemic infections: affecting deeper tissues and

organs.

• Superficial fungal infections can be classified into the dermatomycoses and candidiasis.

• Dermatomycoses are infections of the skin, hair and nails, caused by dermatophytes. The commonest are due to Tinea organisms which cause various forms of “ringworm”.

Page 18: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Topical Antifungal Agents • Azole Derivatives:

– Clotrimazole – Econazole. – Ketoconazole. – Miconazole. – Oxiconazole. – Sulconazole. • Activity against dermatophytes and yeasts, including

Candida albicans.

Page 19: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

• In superficial candidiasis, the yeast-like organism infects the mucous membranes of the mouth (thrush), the vagina (vaginal thrush), or the skin (penis).

• Systemic diseases (infections) include: systemic candidiasis, cryptoccocal meningitis or endocarditis, pulmonary aspergillosis.

Antifungal Chemotherapy

Page 20: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:
Page 21: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Azole Antifungal Agents

• The azole antifungal agents can be divided into two broad classes : the Imidazoles and the Triazoles.

• They share the same antifungal spectrum and the same mechanism of action.

• They are used topically and systemically, the Triazoles being less toxic and are thus the more widely prescribed.

Page 22: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

• Inhibit fungal sterol 14-a-demethylase

• Impair the biosynthesis of the ergosterol

• Ergosterol is required for the fungal cytoplasmic membrane.

• This leads to cessation of growth.

Azole Antifungal Agents

Page 23: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

The Azole Family

Azole Family

Imidazoles Triazoles

Ketoconazole

Miconazole

Clotrimazole

Fluconazole

Itraconazole

Voriconazole

Page 24: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Topical Azoles

• Clotrimazole and Miconazole are used topically.

• Indications for the topical azoles include ringworm, tinea versicolor and mucocutaneous candidiasis.

• Miconazole is a potent inhibitor of warfarin metabolism ( even topical application)

Page 25: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Other topical Antifungal Agents• Ciclopirox Olamine: Tinea versicolor • Naftifine and Terbinafine: tinea pedis, tinea

cruris, and tinea corporis • Tolnaftate • Nystatin and Amphotericin B: – Only for Candida albicans. – Available as topical preparations, oral suspension,

or vaginal tablets

Page 26: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Antifungal Antibiotics

• Amphotericin and Nystatin are polyene macrolide antibiotics that function by binding to fungal cytoplasmic membranes.

• Thus, they interfere with membrane permeability and transport functions.

• One significant outcome is the loss of cellular K+.

• The polyene macrolides are very poorly absorbed orally and they are reluctant to pass through mucous membranes.

Page 27: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Polyene Antifungals: Amphotericine B & Nystatin

• Mechanism of action: Polyene antifungal drugs bind to the fungal cell membrane component ergosterol, leading to increased fungal cell membrane permeability and the loss of intracellular constituents.

Yeast cell cytoplasm

Cell membrane

Page 28: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Amphotericin B

• A polyene antifungal drug produced by the actinomycete Streptomyces.

• Amphotericin has a lesser affinity for the mammalian cell membrane component cholesterol, but this interaction does account for most adverse toxic effects associated with this drug.

• Amphotericin B is most commonly used to treat serious disseminated yeast and dimorphic fungal infections in immuno-compromised hospitalized patients.

• Amphoteracin B can be given IV

Page 29: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

• Side effects: – Fever, chills, and tachypnea commonly occur shortly after the

initial intravenous doses of amphotericin B – Other side effects include anaemia, hypokalaemia, liver

damage, thrombocytopenia and anaphylatic reactions. – In short, its a very toxic drug.

• Main toxicity of Amphotericin is renal. • 80% of patients get reduction in kidney function which

generally recovers after treatment.

• Nephrotoxicity is the most common and the most serious long-term toxicity of amphotericin B administration

Amphotericin B

Page 30: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

•Nystatin is limited to the topical treatment of superficial infections caused by C. albicans.

•Infections commonly treated by this drug include oral candidiasis (thrush), mild esophageal candidiasis and vaginitis.

•Too toxic for systemic use

Nystatin

Page 31: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Oral Antifungal Agents• Azole Derivatives:

– Fluconazole. – Itraconazole. – Ketoconazole. • Affect the permeability of fungal cell membrane

through alteration of sterol synthesis. • Effective in systemic mycosis, mucocutaneous

candidiasis, and other cutaneous infections. • Might have systemic side effects: hepatitis and liver

enzyme elevations, and interactions.

Page 32: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Oral Antifungal Agents• Azole Derivatives. • Griseofulvin: – Effective against epidermophyton, microsporum, and

trichophton. – Requires prolonged treatment:

• 4-6 weeks for the scalp. • 6 months for fingernails. • 8-18 months for toenails. • Has many side effects.

• Terbinafine: – Recommended for onchomycosis (ringworm of the nail)

• 6 weeks for fingernails. • 12 weeks for toenails.

Page 33: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Topical Antiviral Agents• Acyclovir.

• Valacyclovir.

• Penciclovir.

• Famciclovir.

– Synthetic guanine analogs with inhibitory activity against herpes viruses.

– Ointments and creams are useful for recurrent orolabial herpes simplex infection

Page 34: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Immunomodulators• Imiquimod: – For external genital and perianal warts. (condyloma

acuminatum) – Actinic keratosis on the face and scalp. – Primary basal cell carcinoma. – Stimulates peripheral mononuclear cells to release

interferon- ά and to stimulate macrophages to produce interleukins-1,-6, and -8 and tumor necrosis factor-ά.

• Tacrolimus. • Pimecrolimus. – Useful for atopic dermatitis. – Inhibit T-lymphocyte activation and prevent release

of inflammatory cytokines and mast cell mediators

Page 35: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Ectoparasiticides• Permethrin:

– Toxic to Pediculus humanus, Pthirus pubis, and Sarcoptes scabiei

– Pediculosis:cream applied for 10 minutes and then rinsed off with warm water.

– Scabies: cream applied for the whole body for 8-14 hours.

• Lindane (Hexachlorocyclohexane): – 10% absorbed and concentrated in fatty tissues. – Can cause neurotoxicity and hematoxicity

• Crotamiton: drug that is used both as a scabicidal (for treating scabies) and as a general antipruritic

• Sulfur. • Malathion.

Page 36: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Agents affecting Pigmentation• Hydroquinone: topical application skin whitening to reduce

the color of skin

• Monobenzone Monobenzone may be toxic to melanocytes resulting in

permanent depigmentation.

• Mequinol – Topical hydroquinone and mequinol usually result in

temporary lightening.

• Reduce hyperpigmentation of skin by inhibiting the enzyme tyrosinase which will interfere with biosynthesis of melanin

Page 37: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Agents affecting Pigmentation• Trioxsalen.

• Methoxsalen.

– Are psoralens used for the repigmentation of depigmented macules of vitiligo.

– Must be photoactivated by long-wave-length ultraviolet light (320-400nm) to produce a beneficial effect.

– They intercalate with DNA. – Can cause cataract and skin cancer.

Page 38: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Sunscreens and Sunshades

• Sunscreens absorb UV light.

– Examples are para amino benzoic acid (PABA) and its esters.

• Sunshades are opaque materials that reflect light, like titanium dioxide.

• Useful in polymorphous light eruption, lupus erythematosus, and drug –induced photosensitivity.

Page 39: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Acne Preparations

• Retinoic Acid and Derivatives:

– Retinoic Acid. – Adapalene. – Tazarotene.

Page 40: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Acne Preparations• Retinoic Acid and Derivatives: – Retinoic Acid( Tretinoin): is the acid form of Vitamin A.

Stabilizes lysosomes, increases RNA polymerase activity, increases PGE2, cAMP, and cGMP levels, and increases the incorporation of thymidine into DNA.

– Decreases cohesion between epidermal cells and increases epidermal cell turnover. This will result in expulsion of open comedones and the transformation of closed comedones into open ones.

– Also, promotes dermal collagen synthesis, new blood vessel formation, and thickening of the epidermis, which helps diminish fine lines and wrinkles.

– Can cause erythema and dryness. – Tumerogenic in animals

Page 41: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Acne Preparations• Isotretinoin( Accutane):

– Restricted for severe cystic acne resistant to standard treatment.

– Inhibits sebaceous gland size and function. – Given orally: 1–2 mg/kg, given in two divided doses

daily for 4–5 months – Toxic: dryness, itching, headache, corneal

opacities, pseudotumor cerebri, inflammatory bowel disease, anorexia, alopecia, and muscle and joint pains. Also lipid abnormalities.

– Teratogenicity

Page 42: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Acne Preparations• Benzoyl Peroxide:

– Penetrates the stratum corneum or follicular openings and converted to benzoic acid within the epidermis and dermis.

– Has antimicrobial activity against P. acnes and peeling and comedolytic effects.

– Can be combined with erythromycin or clindamycin.

– Can cause bleaching of hair or colored fabrics. • Azelaic Acid:

– Has antimicrobial activity.

Page 43: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Drugs for Psoriasis• Acitretin: – Related to isotretinoin. – Given orally. – Hepatotoxic and teratogenic. – Patients should not become pregnant for 3

years after stopping treatment, and also should not donate blood.

Page 44: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Drugs for Psoriasis

• Tazarotene: – Topical. – Anti-inflammatory and antiproliferative

actions. – Teratogenic. Also, can cause burning,

stinging, peeling, erythema, and localized edema of skin.

• Calcipotiene: – Synthetic vitamin D3 derivative

Page 45: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Drugs for Psoriasis• Biologic Agents: – Alefacept: • Immunosuppressive dimer fusion protein of

CD2 linked to the Fc portion of human IgG1.

– Efalizumab: • Recombinant humanized IgG1 monoclonal

antibody. • Withdrawn :progressive multifocal

leukoencephalopathy (PML), • Can cause thrombocytopenia.

– Etanercept: • Dimeric fusion protein of TNF receptor linked

to the Fc portion of human IgG1.

Page 46: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Anti-inflammatory Agents• Topical Corticosteroids: – Hydrocortisone. – Prednisolone and Methylprednisolone. – Dexamethasone and Betamethasone. – Triamcinolone. – Fluocinonide.

Page 47: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Anti-inflammatory Agents• Topical Cortcosteroids: – Dermatologic disorders very responsive to

steroids: • Atopic dermatitis. • Seborrheic dermatitis. • Lichen simplex chronicus. • Pruritus ani. • Allergic contact dermatitis. • Eczematous dermatitis. • Psoriasis

Page 48: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Anti-inflammatory Agents• Topical Cortcosteroids: – Adverse Effects: • Suppression of pituitary-adrenal axis. • Systemic effects. • Skin atrophy. • Erythema. • Pustules. • Acne. • Infections. • Hypopigmentation. • Allergic contact dermatitis.

Page 49: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Anti-inflammatory Agents• Topical Cortcosteroids. • Tar compounds: – Mainly for psoriasis, dermatitis, and lichen

simplex chronicus

– Can cause irritant folliculitis, phototoxicity, and allergic contact dermatitis.

Page 50: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Keratolytic and Destructive Agents• Salicylic acid: – Solubilizes cell surface proteins resulting in

desquamation of keratotic debris. – Keratolytic in 3-6% concentration, but

destructive in higher concentrations. – Locally, can cause urticaria, anaphylactic

and erythema multiforme reactions, irritation, inflammation, and ulceration.

Page 51: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Keratolytic and Destructive Agents

• Propylene Glycole:

– Usually used as a vehicle for organic compounds. – Used alone as a keratolytic agent in

concentrations of 40%- 70%, with plastic occlusion, or in gel with 6% salicylic acid.

– Minimally absorbed, oxidized in liver to lactic acid and pyruvic acid.

– Develops an osmotic gradient through the stratum corneum, thereby increasing hydration of the outer layers of skin.

Page 52: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Keratolytic and Destructive Agents

• Urea: – Has a humectant activity, i.e. softening and

moisturizing effect on the stratum corneum.

– Increases water content as a result of its hygroscopic characteristics.

– Decreases the unpleasant oily feel of dermatologic preparations.

–When absorbed, it is excreted in urine.

Page 53: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Keratolytic and Destructive Agents

• Flurouracil:

– Antimetabolite that resembles uracil and inhibits thymidylate synthetase, thus interferes with DNA and may be RNA synthesis.

– Used in multiple actinic keratosis.

Page 54: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Keratolytic and Destructive Agents• Nonsteroidal Anti-inflammatory Drugs:

– 3% gel formulation diclofenac.

• Aminolevulinic Acid:

– Used in actinic keratosis. – After topical application(20%) and exposure to

light, produces a cytotoxic superoxide and hydroxyl radicals

Page 55: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Antipruritic Agents• Doxepine: – Potent H1 and H2 – receptor antagonist. – Can cause drowsiness and anticholinergic

effects. • Pramoxine: – Is a topical local anesthetic agent.

Page 56: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Trichogenic and Antitrichogenic Agents• Minoxidil (Rogaine):

– Designed as an antihypertensive agent. – Effective in reversing the progressive

miniaturization of terminal scalp hairs associated with androgenic alopecia.

– Vertex balding is more responsive than frontal balding.

Page 57: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Trichogenic and Antitrichogenic Agents• Minoxidil.

• Finasteride (Propecia):

– 5ά-reductase inhibitor which blocks the conversion of testosterone to dihydrotestosterne.

– Oral tablets. – Can cause decreased libido, ejaculation disorders,

and erectile dysfunction.

Page 58: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Trichogenic and Antitrichogenic Agents• Minoxidil.

• Finasteride.

• Eflornithine:

– Is an irreversible inhibitor of ornithine decarboxylase, therefore, inhibits polyamine synthesis. Polyamines are important in cell division and hair growth.

– Effective in reducing facial hair growth in 30% of women when used for 6 months.

Page 59: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Drugs for Leishmania Caused by three Leishmania species:

L.tropica causes: Cutaneous leishmaniasis or oriental sore.

L. brazeliensis causes: Mucocutaneous leishmaniasis.

L. Donovani causes: Visceral leishmaniasis

Page 60: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Sodium StibogluconatePentravalent antimonial Binds to SH groups on proteins. Typical preparations contain 30% to 34% pentavalent

antimony by weight as well as m-chlorocresol added as a preservative.

Also, inhibits phosphofructokinase Local, IM or slow IV, irritant. Given for 20-28 days. Drug of choice for all forms of leishmaniasis. Resistance is increasing, especially in India. Cough, V, D, myalgia, arthralgia, ECG changes, Rash,

Pruritus.

Page 61: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Amphotericin• Antifungal agent, difficult to use, and

toxic. • Alternative therapy for visceral

leishmaniasis, especially in areas with high resistance.

Page 62: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Miltefosine• For visceral leishmaniasis. • Given orally, for 28 days. • Causes V & D, hepatotoxicity,

nephrotoxicity, and it is teratogenic.

Page 63: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Pentamidine

• Inhibits DNA replication.

• Also, DHF reductase inhibitor

• Given IM or IV injection and Inhalation

• Binds avidly to tissues, not the CNS.

Page 64: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

PentamidineLeishmaniasis: Alternative to Na stibogluconate

Pneumocystis jiroveci: Treatment and prophylaxis of patients who

cannot tolerate or fail other drugs.

Trypanosomiasis: For early hemolymphatic stage.

Page 65: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Pentamidine• Adverse Effects:

• Rapid Infusion: Hypotension, tachycardia, dizziness.

• Pain at the injection site.

• Others: Pancreatic, Renal, and Hepatic toxicity.

Page 66: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Antilepromatous Drugs• Dapsone and Sulphones: – Related to sulphonamides. – Inhibit folate synthesis. – Resistance develops. – Combined with Rifampin and Clofazimine. – Also used for Pn. Jeroveci in AIDS patients. –Well absorbed and distributed. – Retained in the skin, muscle, liver and kidney.

Page 67: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Antilepromatous Drugs• Dapsone and Sulphones: – Hemolysis, particularly in G-6-PD

deficiency. – GIT intolerance

– Fever, Pruritus, Rashes. – Erythema Nodosum Leprosum:

suppressed by steroids or thalidomide.

Page 68: Dermatologic Pharmacology - JU Medicine · Dermatologic Pharmacology Variables affecting Pharmacologic Response: • Regional variation in drug penetration • Concentration gradient:

Antilepromatous Drugs• Rifampin: – Discussed with antituberculous drugs.

• Clofazimine: – Binds to DNA. – Stored widely in RES and skin. – Released slowly from storage sites, t1/2 = 2

months. – Given for sulphone- resistant or intolerant cases. – Causes skin discoloration (red-brown to black)

and GIT intolerance.